Last updated: February 10, 2025
Sponsor: Ataturk University
Overall Status: Completed
Phase
N/A
Condition
Memory Loss
Mild Cognitive Impairment
Stroke
Treatment
Reliability and Validity Study
Clinical Study ID
NCT06313021
2023.12.03
Ages 40-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Individuals between the ages of 40 and 75,
Individuals who volunteer to participate in the research,
Individuals diagnosed with stroke,
Individuals who do not have cooperation and communication problems
Exclusion
Exclusion Criteria:
Those with neurological problems other than stroke (patients diagnosed withAlzheimer's, Parkinson's, Dementia, MS)
Those with perceptual problems
Individuals with cooperation and communication problems
Study Design
Total Participants: 64
Treatment Group(s): 1
Primary Treatment: Reliability and Validity Study
Phase:
Study Start date:
January 15, 2024
Estimated Completion Date:
December 15, 2024
Study Description
Connect with a study center
Ataturk University
Erzurum,
TurkeySite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.